Details for New Drug Application (NDA): 200644
✉ Email this page to a colleague
The generic ingredient in ACETYLCYSTEINE is acetylcysteine. There are three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the acetylcysteine profile page.
Summary for 200644
Tradename: | ACETYLCYSTEINE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | acetylcysteine |
Patents: | 0 |
Pharmacology for NDA: 200644
Mechanism of Action | Reduction Activity |
Physiological Effect | Decreased Respiratory Secretion Viscosity Increased Glutathione Concentration |
Medical Subject Heading (MeSH) Categories for 200644
Suppliers and Packaging for NDA: 200644
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 200644 | ANDA | Fresenius Kabi USA, LLC | 63323-963 | 63323-963-44 | 4 VIAL, SINGLE-DOSE in 1 CARTON (63323-963-44) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-963-41) |
ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 200644 | ANDA | Fresenius Kabi USA, LLC | 63323-963 | 63323-963-30 | 4 VIAL, SINGLE-DOSE in 1 CARTON (63323-963-30) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-963-21) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 6GM/30ML (200MG/ML) | ||||
Approval Date: | Nov 7, 2012 | TE: | AP | RLD: | No |
Complete Access Available with Subscription